Overview

Tranexamic Acid in Dacryocystorhinostomy

Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Single dose tranexamic acid (TA) before dacryocystorhinostomy (DCR) operation: a prospective, double blind, placebo controlled study. The study hypothesis: TA in DCR might reduce the intraoperative and postoperative bleeding in DCR surgery, and might reduce the duration of the surgery.
Phase:
N/A
Details
Lead Sponsor:
HaEmek Medical Center, Israel
Treatments:
Tranexamic Acid